As part of a series of legal updates on the Washington My Health My Data Act (“WMHMDA”), writers at Quarles & Brady are exploring various factors and intricacies of the act that are influencing the privacy sector – and not just for the health and life sciences industry. This is the focus of the tenth part in their series.
Guided by the team at Quarles & Brady LLP, the series takes an in-depth look into the numerous elements of the WMHMDA, and how it is causing ripples within the data privacy landscape. This legislation is not impacting only the health and life sciences industry, but the wider corporate sector as well.
As the series continues, it dissect the operational realities of the Act and its potential next steps, enabling legal professionals and entities to navigate the complexities of this new legislation. The evolving nature of digital privacy norms, the potential impact on other sectors beyond the health and life sciences, and the varied legal implications are among the considerations being discussed.
With this commentary, Quarles & Brady helps to demystify the WMHMDA, allowing readers to gain an inherent understanding of its nuances and its broader impacts on data privacy within corporate environments.